Arakawa Chemical Industries, Ltd. (TYO:4968)
1,715.00
-161.00 (-8.58%)
Nov 6, 2026, 3:30 PM JST
TYO:4968 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 88,330 | 82,135 | 80,236 | 72,222 | 79,431 | 80,515 | |
Revenue Growth | 8.68% | 2.37% | 11.10% | -9.08% | -1.35% | 14.09% |
Cost of Revenue | 68,196 | 64,283 | 63,743 | 60,540 | 67,859 | 62,544 |
Gross Profit | 20,134 | 17,852 | 16,493 | 11,682 | 11,572 | 17,971 |
Selling, General & Admin | 12,629 | 11,909 | 11,956 | 10,936 | 11,082 | 11,132 |
Research & Development | 3,043 | 3,043 | 3,058 | 2,965 | 3,024 | 3,100 |
Amortization of Goodwill & Intangibles | - | - | - | - | - | 76 |
Operating Expenses | 16,468 | 15,748 | 15,832 | 14,342 | 14,479 | 14,667 |
Operating Income | 3,666 | 2,104 | 661 | -2,660 | -2,907 | 3,304 |
Interest Expense | -506 | -479 | -417 | -331 | -224 | -185 |
Interest & Investment Income | 389 | 367 | 341 | 323 | 280 | 257 |
Currency Exchange Gain (Loss) | 180 | 61 | 151 | 172 | 413 | 329 |
Other Non Operating Income (Expenses) | 285 | 337 | 118 | 85 | -250 | -140 |
EBT Excluding Unusual Items | 4,014 | 2,390 | 854 | -2,411 | -2,688 | 3,565 |
Gain (Loss) on Sale of Investments | 276 | 376 | 1,268 | 511 | 303 | 3 |
Gain (Loss) on Sale of Assets | -161 | -207 | 745 | -457 | 775 | -279 |
Asset Writedown | -775 | - | - | -7 | -1,838 | -349 |
Legal Settlements | -155 | -155 | - | - | - | - |
Other Unusual Items | 934 | - | - | 946 | -1,205 | -1 |
Pretax Income | 4,133 | 2,404 | 2,867 | -1,418 | -4,653 | 2,939 |
Income Tax Expense | 2,202 | 1,738 | 1,805 | 938 | 883 | 1,132 |
Earnings From Continuing Operations | 1,931 | 666 | 1,062 | -2,356 | -5,536 | 1,807 |
Minority Interest in Earnings | 1,714 | 1,535 | 1,582 | 1,314 | 595 | -305 |
Net Income | 3,645 | 2,201 | 2,644 | -1,042 | -4,941 | 1,502 |
Net Income to Common | 3,645 | 2,201 | 2,644 | -1,042 | -4,941 | 1,502 |
Net Income Growth | 110.21% | -16.75% | - | - | - | -30.75% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 183.73 | 110.94 | 133.27 | -52.52 | -249.06 | 75.71 |
EPS (Diluted) | 183.73 | 110.94 | 133.27 | -52.52 | -249.06 | 75.71 |
EPS Growth | 110.21% | -16.75% | - | - | - | -30.75% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 3,542 | 496 | 712 | -5,611 | -6,621 | -2,160 |
Free Cash Flow Per Share | 178.54 | 25.00 | 35.89 | -282.83 | -333.74 | -108.88 |
Dividend Per Share | 25.000 | 50.000 | 49.000 | 48.000 | 48.000 | 48.000 |
Dividend Growth | -50.00% | 2.04% | 2.08% | 0% | 0% | 4.35% |
Gross Margin | 22.79% | 21.73% | 20.56% | 16.18% | 14.57% | 22.32% |
Operating Margin | 4.15% | 2.56% | 0.82% | -3.68% | -3.66% | 4.10% |
Profit Margin | 4.13% | 2.68% | 3.29% | -1.44% | -6.22% | 1.86% |
Free Cash Flow Margin | 4.01% | 0.60% | 0.89% | -7.77% | -8.34% | -2.68% |
EBITDA | 9,431 | 8,088 | 6,777 | 3,191 | 1,570 | 6,500 |
EBITDA Margin | 10.68% | 9.85% | 8.45% | 4.42% | 1.98% | 8.07% |
D&A For EBITDA | 5,765 | 5,984 | 6,116 | 5,851 | 4,477 | 3,196 |
EBIT | 3,666 | 2,104 | 661 | -2,660 | -2,907 | 3,304 |
EBIT Margin | 4.15% | 2.56% | 0.82% | -3.68% | -3.66% | 4.10% |
Effective Tax Rate | 53.28% | 72.30% | 62.96% | - | - | 38.52% |